These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 9409083)

  • 21. Benzodiazepines for the treatment of panic disorder and generalized anxiety disorder: clinical issues and future directions.
    Bradwejn J
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S109-13. PubMed ID: 7905780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term management of panic disorder.
    Pollack MH
    J Clin Psychiatry; 1990 May; 51 Suppl():11-3; discussion 50-3. PubMed ID: 1970813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two cases of alprazolam-induced hyperprolactinemia in patients with panic disorder.
    Shioiri T; Kita N; Takahashi S
    Int Clin Psychopharmacol; 1996 Jun; 11(2):149-52. PubMed ID: 8803653
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of extended-release benzodiazepines in the treatment of anxiety: a risk-benefit evaluation with a focus on extended-release alprazolam.
    Klein E
    J Clin Psychiatry; 2002; 63 Suppl 14():27-33. PubMed ID: 12562116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain.
    Beitman BD; Basha IM; Trombka LH; Jayaratna MA; Russell B; Flaker G; Anderson S
    J Fam Pract; 1989 Feb; 28(2):177-80. PubMed ID: 2644392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The influence of alprazolam on the symptoms of anxiety and depression].
    Małyszczak K; Kiejna A
    Psychiatr Pol; 1997; 31(6):745-52. PubMed ID: 9515306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alprazolam (Xanax, and others) revisited.
    Med Lett Drugs Ther; 2005 Jan; 47(1200):5-7. PubMed ID: 15647704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a patient-reported assessment to identify placebo responders in a generalized anxiety disorder trial.
    Feltner D; Hill C; Lenderking W; Williams V; Morlock R
    J Psychiatr Res; 2009 Oct; 43(15):1224-30. PubMed ID: 19423131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of 6 different methods for lorazepam withdrawal. A controlled study, hydroxyzine versus placebo].
    Lemoine P; Touchon J; Billardon M
    Encephale; 1997; 23(4):290-9. PubMed ID: 9417395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discontinuation of alprazolam after long-term treatment of panic-related disorders.
    DuPont RL; Swinson RP; Ballenger JC; Burrows GD; Noyes R; Rubin RT; Rifkin A; Pecknold JC
    J Clin Psychopharmacol; 1992 Oct; 12(5):352-4. PubMed ID: 1479053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Xanax XR for panic disorder.
    Med Lett Drugs Ther; 2003 May; 45(1157):43-4. PubMed ID: 12766702
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacotherapy of anxious disorders.
    Bourin M; Lambert O
    Hum Psychopharmacol; 2002 Dec; 17(8):383-400. PubMed ID: 12457374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Alprazolam versus lorazepam in the treatment of anxiety: controlled clinical study].
    Bernardi F; Fossi L; Faravelli C; Corsini GU; Varricchio MC
    Riv Patol Nerv Ment; 1984; 105(1):1-13. PubMed ID: 6571441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The speed of onset of action of alprazolam-XR compared to alprazolam-CT in panic disorder.
    Sheehan DV; Sheehan KH; Raj BA
    Psychopharmacol Bull; 2007; 40(2):63-81. PubMed ID: 17514187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A double-blind study of alprazolam and lorazepam in the treatment of anxiety.
    Ruiz AT
    J Clin Psychiatry; 1983 Feb; 44(2):60-2. PubMed ID: 6131066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An open label trial of alprazolam in comorbid irritable bowel syndrome and generalized anxiety disorder.
    Tollefson GD; Luxenberg M; Valentine R; Dunsmore G; Tollefson SL
    J Clin Psychiatry; 1991 Dec; 52(12):502-8. PubMed ID: 1752852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiagabine in adult patients with generalized anxiety disorder: results from 3 randomized, double-blind, placebo-controlled, parallel-group studies.
    Pollack MH; Tiller J; Xie F; Trivedi MH
    J Clin Psychopharmacol; 2008 Jun; 28(3):308-16. PubMed ID: 18480688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction of pharmacological and psychological treatments of anxiety.
    Lader MH; Bond AJ
    Br J Psychiatry Suppl; 1998; (34):42-8. PubMed ID: 9829016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.